K2VC

K2VC is an early-stage venture capital firm based in Beijing, China, investing in technology, media, telecommunications, and life sciences companies to foster innovation and industrial upgrades. The firm manages approximately 10 billion RMB in assets under management across RMB and USD funds, including K2 Angel Partners for TMT and K2 Bio Partners for biotech, medtech, and life sciences. It has invested in over 700 portfolio companies, with K2 Bio Partners notably leading the Series Pre-A investment in ProfoundBio in 2020, a company later acquired by Genmab for $1.8 billion in 2024. Key personnel include Managing Partners Yang Zhao and Yuan Cui, and Partner Yao Wu. K2VC was founded in 2010 by Chen Keyi and Bao Fan. Its business model centers on venture capital firm earning returns through investments in portfolio companies and fund management.